Prognostic impact of procarbazine in R-MPV followed by reduced-dose whole-brain radiotherapy and cytarabine for primary central nervous system lymphoma.
Saved in:
| Title: | Prognostic impact of procarbazine in R-MPV followed by reduced-dose whole-brain radiotherapy and cytarabine for primary central nervous system lymphoma. |
|---|---|
| Authors: | Matsumoto S; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Kurihara Y; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Masuda Y; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Nara K; Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan., Yuasa M; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Honda A; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Takada T; Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan., Kurokawa M; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 Feb; Vol. 67 (3), pp. 638-646. Date of Electronic Publication: 2025 Dec 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2025.2604305 |
